NDA 064200 describes CEFOTAXIME, which is a drug marketed by
Fresenius Kabi Usa,
Hikma,
Wockhardt,
B Braun,
Aurobindo Pharma,
Aurobindo Pharma Ltd,
Cephazone Pharma,
Hospira,
Hospira Inc, and
Lupin, and is included in fourteen NDAs. It is available from
one supplier. Additional details are available on the
CEFOTAXIME profile page.
The generic ingredient in CEFOTAXIME is
cefotaxime sodium. There are fourteen
drug master file entries for this compound. One
supplier is listed for this compound. Additional details are available on the
cefotaxime sodium profile page.